Evidence map›Paper›PMID 30360412›Full record

ArticleMolecules (Basel, Switzerland)2018

A Potent Tyrosinase Inhibitor, (

Chang Seok Kim, Sang Gyun Noh, Yujin Park, Dongwan Kang, Pusoon Chun, Hae Young Chung, Hee Jin Jung, Hyung Ryong Moon

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Prenylated flavonoids fromFrontiers in pharmacology · 2024
    Article
  5. Tyrosinase Inhibitors: A Perspective.Molecules (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Novel Anti-Melanogenic Compounds, (Molecules (Basel, Switzerland) · 2021
    Article
  12. Article
  13. (Molecules (Basel, Switzerland) · 2020
    Article
  14. Anti-Melanogenesis Activity of 6-Molecules (Basel, Switzerland) · 2020
    Article
  15. Article
  16. Simultaneous Determination of Six Isoflavones fromMolecules (Basel, Switzerland) · 2020
    Article
  17. Computational and structural biotechnology journal · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chang Seok KimCollege of Pharmacy, Pusan National University, Busan 46241, Korea. autoimmuneds@naver.com.
Sang Gyun NohCollege of Pharmacy, Pusan National University, Busan 46241, Korea. rskrsk92@naver.com.
Yujin ParkCollege of Pharmacy, Pusan National University, Busan 46241, Korea. pyj10@pusan.ac.kr.
Dongwan KangCollege of Pharmacy, Pusan National University, Busan 46241, Korea. 3607@pusan.ac.kr.
Pusoon ChunCollege of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae, Gyeongnam 50834, Korea. pusoon@inje.ac.kr.
Hae Young ChungCollege of Pharmacy, Pusan National University, Busan 46241, Korea. hyjung@pusan.ac.kr.
Hee Jin JungCollege of Pharmacy, Pusan National University, Busan 46241, Korea. hjjung2046@pusan.ac.kr.
Hyung Ryong MoonCollege of Pharmacy, Pusan National University, Busan 46241, Korea. mhr108@pusan.ac.kr.ORCID 0000-0003-1119-7112
Pusan National University · KRInje University · KR

Funding

National Research Foundation of Korea NRF-2018R1A6A3A11047399
6 · The paper itself

Abstract

In this study, we designed and synthesized eight thiophene chalcone derivatives (

Indexed as

AnimalsDose-Response Relationship, DrugEnzyme ActivationEnzyme InhibitorsKineticsMelanoma, ExperimentalMiceModels, MolecularMolecular ConformationMolecular StructureMonophenol MonooxygenaseProtein BindingStructure-Activity RelationshipThiazolidinedionesEnzyme InhibitorsMonophenol MonooxygenaseThiazolidinedionesanti-melanogenesis(E)-3-(2,4-dihydroxyphenyl)-1-(thiophene-2-yl)prop-2-en-1-onethiophene chalconetyrosinase inhibitor

Identifiers

PMID30360412
PMCPMC6222382
OpenAlexW2896086184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.